Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Development of the Lymphatic System

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Pleural Effusion II: Symptoms and Management

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

Lymphoid Cells and Tissues

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Necrotizing Pneumonia and Bronchopleural Fistula in Children: The Use of Chest CT Total Severity Score to Predict BPF formation.

Annals of the American Thoracic Society·2026

Same author

Sclerosing and Embolizing Gel for Venous Embolization: Feasibility Study in a Porcine Model.

Journal of vascular and interventional radiology : JVIR·2026

Same author

Embolization of Extracranial Arteriovenous Malformations: Interventional Approaches according to the Yakes Classification System.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026

Same author

Building an Interdisciplinary Clinic for Upper Extremity Reconstruction in Spinal Cord Injury: The Montreal TetraHand Experience.

Plastic and reconstructive surgery. Global open·2026

Same author

Interventional Management of Pulmonary Arteriovenous Malformations: Imaging Primer.

Radiographics : a review publication of the Radiological Society of North America, Inc·2025

Same author

High-fidelity virtual endovascular aneurysm repair model as a decision-making tool.

Medical & biological engineering & computing·2025

Search research articles

Related Experiment Video

Updated: Jan 1, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

Common (Cystic) Lymphatic Malformations: Current Knowledge and Management.

Josée Dubois¹, Frédéric Thomas-Chaussé¹, Gilles Soulez²

¹CHU Sainte-Justine, Montreal, Canada.

Techniques in Vascular and Interventional Radiology

|December 23, 2019

Summary

Treating lymphatic malformations (LMs) now includes surgery, sclerotherapy, and targeted drug therapies. Standardizing LM characterization is key to understanding treatment outcomes and balancing risks versus benefits.

Keywords:

lymphatic malformation sclerotherapy treatment

More Related Videos

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Jan 1, 2026

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

A Revised Method for Inducing Secondary Lymphedema in the Hindlimb of Mice

Published on: November 2, 2019

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

Area of Science:

Vascular Anomalies
Molecular Biology
Medical Therapeutics

Background:

Lymphatic malformations (LMs) are congenital vascular anomalies with diverse clinical presentations.
Treatment strategies for LMs have advanced, incorporating surgical, interventional, and pharmacological approaches.
Recent molecular biology research offers new insights into LM pathogenesis and targeted therapies.

Purpose of the Study:

To review current therapeutic options for lymphatic malformations.
To emphasize the need for standardized imaging and classification of LMs.
To guide clinicians in balancing treatment risks and benefits for patients with LMs.

Main Methods:

Literature review of surgical, sclerosing, and targeted biological therapies for LMs.
Discussion of the importance of standardized lesion characterization and imaging.
Analysis of risk-benefit profiles for various treatment modalities.

Main Results:

Multiple treatment modalities exist for lymphatic malformations, including surgery, sclerotherapy, and targeted drug therapies.
Standardized imaging and characterization are crucial for evaluating treatment efficacy.
A risk-benefit assessment is essential for optimal patient management.

Conclusions:

The management of lymphatic malformations has evolved, offering diverse therapeutic avenues.
Standardization in LM assessment will enhance understanding of treatment outcomes.
Informed decision-making requires careful consideration of risks and benefits for each patient.